[Results of treatment of bacterial inflammation of the skin with enoxacin].
In a microbiologically controlled, open study the 4-quinolone derivative enoxacin was tested in 51 patients suffering from infectious dermatoses. Clinical cure or improvement was observed in 91% of the patients, microbiological cure occurred in 65%. According to the results of our trial enoxacin is recommended as a therapeutic alternative, especially for the treatment of dermatitis caused by gram-negative bacilli.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003872:Dermatitis / Q000188:drug therapy*; D015365:Enoxacin; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009287:Naphthyridines / Q000627:therapeutic use*; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D000890:Anti-Infective Agents; D009287:Naphthyridines; D015365:Enoxacin
Ergebnisse der Behandlung bakterieller Entzündungen der Haut mit Enoxacin.